What is clinical decision support and how does it help patient care?

What clinical decision support is

Clinical decision support is any tool that gives you patient-specific information at the moment you make a decision. It does not make the decision. It puts the right fact in front of you, such as an interaction, a missed monitoring test or a relevant guideline, when you can still act on it.

In general practice it comes in several forms:

• Prescribing checks: warnings about interactions, allergies, contraindications and doses when you prescribe.
• Alerts and reminders: overdue monitoring, recalls, or a flag that a result needs action.
• Templates and protocols: structured consultation templates that prompt the right questions and record coded answers.
• Risk calculators: tools that turn patient data into a risk score to guide treatment.
• Guidance at the point of care: links to the BNF, NICE guidance or local pathways from inside the record.
• AI tools: from scribes that draft notes and suggest codes, to tools that suggest diagnoses.

Why it matters more in private practice

In NHS general practice you prescribe with the full GP record in front of you. In private practice you usually cannot see it (see can I access the NHS record?). Many private GPs also work alone, consult remotely or see a patient once. Each of these removes a safety net that NHS practice provides without anyone noticing.

Good decision support puts some of that net back. It cannot replace a careful history and medication review, but it catches the interaction you did not think of, or the allergy recorded at registration that the patient forgot to mention.

How prescribing checks work

Two things sit behind a prescribing warning.

1. A medicines dictionary. In the UK this is usually dm+d, the NHS Dictionary of Medicines and Devices, published by the NHS Business Services Authority. It is the NHS standard for identifying medicines and devices across clinical systems, so a prescription means the same thing in every system.
2. A clinical knowledge base. The rules about interactions, contraindications and doses come from a drug knowledge source built into the system. Different systems use different sources, so ask which one yours uses and how often it is updated.

Checks only work on what the system knows. If allergies are typed as free text, or current medicines from the NHS GP are not recorded, the system cannot warn you. That is one of the strongest arguments for a coded electronic record over paper (see can I use paper notes?).

The limits

• Alert fatigue. Too many low-value warnings teach everyone to click through them. Check whether alerts can be tuned by severity.
• False reassurance. No warning does not mean safe. The system only knows what has been recorded.
• Gaps. Knowledge bases may not cover unlicensed use, compounded products or some imported medicines.
• AI errors. AI tools can produce confident text that is wrong. NHS England’s guidance on ambient scribes requires clinicians to review and approve outputs before acting on them.

You remain responsible for every decision. Record why you overrode a significant warning.

Regulation you should know about

Software as a medical device

Software with a medical purpose can be a medical device. The MHRA gives examples such as software that calculates medicine doses, or tells someone they have a condition or gives an individual percentage risk score. Medical device software should carry UKCA or CE marking. Report problems with it to the MHRA through the Yellow Card scheme.

For AI scribes, NHS England and the MHRA have said that products solely intended to transcribe and summarise conversations, draft correspondence or suggest clinical codes for a clinician to review are not regulated as medical devices under the current rules. Products intended to support diagnosis, treatment or automated clinical actions are, and need the right certification.

Clinical safety standards

DCB0129 applies to companies that make health IT and DCB0160 to organisations that deploy and use it. As the practice, you are the deploying organisation. Ask each supplier for its DCB0129 status and safety case, and do your own DCB0160 risk assessment before go-live. NHS England is reviewing both standards, so check for updates.

If you introduce an AI scribe, NHS England’s guidance also expects a data protection impact assessment and clear information for patients before you record them.

Questions to ask a supplier

• Which drug knowledge base does the system use, and how often is it updated?
• Does it check interactions, allergies, contraindications and doses? Against coded data only, or free text as well?
• Can alerts be graded by severity, and are overrides recorded?
• What recalls, registers and reminders can it run?
• Are any features medical devices? If so, what marking do they carry?
• What is the supplier’s DCB0129 status, and will it share its hazard log?

Making it work day to day

1. Record allergies and current medicines as coded entries at registration, including what the NHS GP prescribes.
2. Code diagnoses and long-term conditions so recalls and registers can find them.
3. Set recalls for anything you start that needs monitoring.
4. Review overridden alerts every few months as a small audit (see clinical audit).
5. Report significant safety problems with the software to the supplier and, for medical devices, to the MHRA.

For more on reducing error in private practice, see preventing clinical errors.